|
William R. Huckle, Editor
|
Boston, MA
July 7-9, 2020
|
Vascular Biology 2020
Newport, RI
October 25-29, 2020
|
Shop at Amazon?
Help Support NAVBO
|
|
Partner Network Advantage on the NAVBO Job Board
|
Why post your job on NAVBO's career center rather than going directly to the larger job networks?
Pricing on the mass job boards can vary, but to get a job noticed you typically have to sponsor it for $5 - $10 per day, which can add up quickly especially since you also pay for each click the job gets. When you add it all together, you could be spending up to $45 per day on your job posting. But, when posting a job on NAVBO's career center, you simply pay a flat fee! The Premium package includes our Exclusive Extended Partner Network - which means the jobs are broadcast to sites like ZipRecruiter and Jobs2Careers and more for a flat fee.
With special member pricing, you can post a job for as low as $300 with this Partner Network. You never pay for each click, just the flat fee on the NAVBO career center. In addition, the Premium package includes a 60-day job posting making it a great value. The Premium packages also offer features like having your company's logo featured on the career center homepage, having your job appear first in search results, and more.
|
Your data privacy and security are important to NAVBO. To that end, we have updated our privacy policy to reflect recent privacy and security regulation implementations and changes.
Please review our policy as time permits so you have a complete understanding of the data we have, why we have it, and how we use it.
Part of the updates relate directly to the European Union's new General Data Protection Regulation (GDPR) that went into place May 25. The GDPR seeks to improve the transparency of data usage and give end users more control over their own data. We believe these changes are important and will be compliant with the GDPR regulations.
Contact NAVBO if you have any questions or to
change your communication preferences.
Please note, you can unsubscribe to this newsletter at anytime by clicking on the SafeUnsubscribe in the footer.
|
|
 |
|
|
You may not have noticed, but
Dr. Shyh-Jye (Jeff) Lee, National Taiwan University, has been an editor for NAVBO's
Vascular Biology Publications Alert (VBPA) since June 2008 and one of the Senior Editors since August 2010!!! That's some kind of record!
Dr. Lee is stepping down from this position, but NAVBO cannot let him go without thanking him for his many years of service to the vascular biology community. Thank you, Jeff!! Your hard work and commitment are very much appreciated! Best of luck in all you do!
We also want to acknowledge and thank Dr. Radu Stan, Dartmouth Medical School, for his longtime service to NAVBO members as the other Senior Editor of the VBPA. Jeff and Radu have both served since June 2008.
In addition, this is a wonderful opportunity to acknowledge and thank the other editors of the VBPA:
- Rolf Brekken, UT Southwestern
- Susana Cavallero, University of California, Los Angeles/VA Greater Los Angeles Healthcare System
- Monica Hinds, Oregon Health & Science University
- Akiko Mammoto, Medical College of Wisconsin
- Michael May, University of Pennsylvania
- Juan Melero-Martin, Boston Children's Hospital
- Liudmila Romanova, Rush University Medical Center
- Linda Shapiro, University of Connecticut
- Somanath PR Shenoy, University of Georgia
- Kishore Wary, University of Illinois, Chicago
Of course, this means we are now on an Editor Search. If interested please send your CV to [email protected]. Thank you!
See more information below
|
|
25 Years Shows Growth in Productivity and Collaboration
|
Zorina Galis shares 25th anniversary time-capsule at VB2019
 Those fortunate enough to be in Merrill Hall at Asilomar to celebrate NAVBO's silver anniversary last October were treated to an entertaining and informative walk down memory lane by Zorina Galis, charter member, Councilor and stalwart supporter of the organization. Zorina began her talk with a whimsical look back at the cultural touchstones and fashion trends, now scarcely-recognizable, that prevailed in 1994, the year of NAVBO's founding. Splashed across the screen also were pairs of then-and-now photos submitted by courageous members, confirming, in your editor's humble estimation, that a career in vascular biology research keeps one young.
On a more serious note, Zorina presented findings from her exploration of the evolution and impact of "NAVBO Science through the Publications of its Members," conducted with her collaborators Bruce W. Herr II, Medina Sydykanova, Santoshmurti S. Daptardar, and Katy Börner from Indiana University. Using straightforward metrics such as numbers of publications and citations, as well as more complex measures including delineation of co-author networks and topical distributions, Zorina's team produced dramatic evidence that the productivity of and collaboration among NAVBO's members have grown markedly over the organization's quarter-century lifetime. We are grateful to Zorina for her lighthearted but striking reminder of NAVBO's success as a vibrant and collaborative scientific community. Here's to 25 more fruitful years! Oh, and a note to our post-docs and junior faculty: stash some current photos in a safe place right away. What is "now" becomes "then" before you know it.
|
|
|
Meet More of the 2019 Travel Award Recipients
|
|
Next Webinar is February 13
|
Next Week's Webinar
On February 13 at 1:00pm ET, join us for a webinar featuring
Ke Yuan, Boston Children's Hospital, and her presentation titled, "
Mural Cell SDF1 Signaling Is Associated with The Pathogenesis of Pulmonary Arterial Hypertension." Pulmonary artery smooth muscle cells (PASMCs) and pericytes are NG2+ mural cells that provide structural support to pulmonary arteries and capillaries. In pulmonary arterial hypertension (PAH), both mural cell types contribute to PA muscularization but whether similar mechanisms are responsible for their behavior is unknown. Curious to find out more? Join us on February 13.
Click here for more information and to register for the webinar.
Upcoming Webinars
On March 12, we will host a webinar with
Brant Weinstein, NICHD/NIH titled, "
New Insights into Lymphatics and Lymphatic-related Cells from the Zebrafish."
Click here for more information and to register for Dr. Weinstein's webinar.
And on April 2, join
Courtney Griffin, Oklahoma Medical Research Foundation, as she gives her presentation,
"What Chromatin Remodelers Can Teach Us About Vascular Development and Integrity.
Click here for more information and to register for Dr. Griffin's webinar.
Join us!! NAVBO Webinars are free to current NAVBO Members. Non-members can attend for $25 per webinar.
And don't forget you can watch recorded webinars as well - go to
|
|
Vascular Biology Publications Alert
|
|
Seeking New Editor
If you are interested in being an editor for the NAVBO Vascular Biology Publications Alert, please send your CV to [email protected].
Applicants should be current Regular members of NAVBO.
Editors review the abstracts of papers in their assigned journals and select those most appropriate to be included in our Vascular Biology Publications Alert. We have two teams of editors so this task is performed every other month.
Vascular Biology Publications Alert Now Available by Subscription
The NAVBO Vascular Biology Publications Alert will now be available to non-members for a $55 a year subscription. If you would like to receive this alert, but are not a member, please contact Danielle at [email protected].
|
Join the Club on March 19 at 1:00pm ET
The next NAVBO Online Journal Club will be led by William Hughes, Medical College of Wisconsin, and a member of the NAVBO Education Committee. The paper is:
Age Associated Mitochondrial Dysfunction Accelerates Atherogenesis
Daniel J. Tyrrell, Muriel G. Blin, Jianrui Song, Sherri C. Wood, Min Zhang, Daniel A. Beard, Daniel R. Goldstein
Access information will be sent to current NAVBO members via email.
|
|
Promote Your Presentation on the Web Site
|
Current NAVBO Members Can List Their Upcoming Presentations (Oral or Poster) on our Web Site
Keep members, and all who visit our web site, aware of presentations by NAVBO members. If you are attending the meeting, be sure to attend your NAVBO colleague's presentation. If you are also presenting at that meeting, you can attend each other's presentations and offer mutual support! It can also help make you aware when a colleague is in your town so you reach out and arrange an in-person chat. And finally, this listing can also keep you abreast of other relevant meetings and conferences.
There is a form at the bottom of the page for you to add your presentation.
|
Welcome to our New Members:
Sylvain Chemtob,
University of Montreal
Chan Kim,
CHA University Medical School
Rajeev Malhotra, Harvard Medical School
Corina Marziano, University of Virginia
|
Medical innovation center rises from Kobe earthquake rubble
Japan's Kobe Biomedical Innovation Cluster, built as part of earthquake reconstruction to revitalize Kobe's economy after the Great Hanshin-Awaji Earthquake of 1995, provides unique opportunities for researchers to work in an innovative environment with a wealth of resources. KBIC has expanded dramatically in its 21-year history, growing from 18 companies and 200 employees in 2001 to 363 companies boasting more than 11,000 workers in 2019. This public-private partnership is supported by the Foundation for Biomedical Research and Innovation at Kobe, which is headed by Nobel prize laureate Tasuku Honjo and is committed to the incubation of promising technologies and medicines from ideation to commercialization.
Dramatic advances in treatment of sickle cell disease
The remarkable story of Helen Obando, the youngest person in the US to undergo a gene therapy to correct her sickle cell disease, will be featured on the
New York Times online on Feb. 17, 2020. Helen received the breakthrough experimental treatment at Boston Children's Hospital. Sickle cell disease is the most commonly inherited blood disorder in the U.S. and has fated sufferers to a lifetime of intense pain and heightened risk of stroke and organ damage. The outcome of Helen's gene therapy could help determine how an estimated 100,000 people in the U.S. and millions more around the world are treated.
New restrictions on resources for research using fetal tissue
Amy Goldstein reports in
The Washington Post that research into major diseases, including AIDS, Down syndrome and diabetes, may be slowed by a Trump administration decision to limit funding of research that uses fetal tissue. The amended federal funding rules, announced in mid-2019, are already prompting investigators to adjust research objectives and the scope of grants sought from the NIH. The changes have upended funding for the Humanized Mouse Core at UCLA, which has been in operation since the early 1990s and now provides such mice to 70 scientists on campus and around the country. Discouragingly, the new rules require review of proposed work by a centralized ethics advisory board that is not yet established.
|
Feb. 7 - 8, 2020
|
11th Charleston Symposium on Vascular Anomalies |
Feb. 16 - 19, 2020
|
Cerebral Fluid Flow and Function: Lymphatics, Glymphatics and the Choroid Plexus |
March 4 - 5, 2020
|
International Conference on Neurology and Neuroscience |
April 1 - 3, 2020
|
EMBO Workshop - Cell Signalling and Biology of Vascular Malformations |
April 4 - 6, 2020
|
The Microcirculatory Annual Meeting at Experimental Biology 2020 |
April 4 - 7, 2020
|
Experimental Biology 2020 |
July 7 - 9, 2020
|
Vasculata 2020 |
July 11 - 15, 2020
|
ISTH 2020 Congress |
Sept. 9 - 12, 2020
|
21st International Vascular Biology Meeting (IVBM 2020) |
Oct. 3 - 6, 2020
|
11th Kloster Seeon Angiogenesis Meeting |
Oct. 25 - 29, 2020
|
Vascular Biology 2020 |
|
|
|
This month we are highlighting the lab of Dr. Roger Johns, who is a Professor at Johns Hopkins University. Find out more about Dr. Johns' lab at
